|
Market Cap | 20.33M | EPS (ttm) | -0.58 |
P/E | - | EPS this Y | -3.88% |
Forward P/E | - | EPS next Y | 17.43% |
PEG | - | EPS past 5Y | 13.11% |
P/S | 2033.40 | EPS next 5Y | - |
P/B | 0.53 | EPS Q/Q | 27.09% |
Dividend | - | Sales Q/Q | - |
Insider Own | 9.39% | Inst Own | 46.86% |
Insider Trans | 0.00% | Inst Trans | -1.73% |
Short Float | 5.16% | Earnings | May 09/b |
Analyst Recom | 2.00 | Target Price | 3.17 |
Avg Volume | 1.18M | 52W Range | 1.11 - 3.53 |
|
|
|
GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates. The company was founded by Rachel K. King and John L. Magnani on April 4, 2003 and is headquartered in Rockville, MD. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Rock Edwin | Chief Medical Officer | Sep 22 '23 | Buy | 1.38 | 30,403 | 41,956 | 375,403 | Sep 25 04:21 PM | Rock Edwin | Chief Medical Officer | Sep 21 '23 | Buy | 1.38 | 35,000 | 48,300 | 345,000 | Sep 25 04:21 PM | Koenig Scott | Director | Jun 01 '23 | Option Exercise | 0.60 | 21,000 | 12,600 | 36,750 | Jun 02 04:10 PM | Hahn Brian M. | SVP Finance, CFO | May 17 '23 | Sale | 1.95 | 3,700 | 7,215 | 53,143 | May 18 04:27 PM | JUNIUS DANIEL M | Director | May 10 '23 | Buy | 1.56 | 30,000 | 46,800 | 93,250 | May 11 05:08 PM |
|
|
|
|
Market Cap | 3.18M | EPS (ttm) | -1.25 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -9.95% |
P/S | 0.16 | EPS next 5Y | - |
P/B | 0.10 | EPS Q/Q | 37.18% |
Dividend | - | Sales Q/Q | 43.74% |
Insider Own | 36.27% | Inst Own | 5.63% |
Insider Trans | 0.00% | Inst Trans | -6.42% |
Short Float | 2.92% | Earnings | Apr 01/a |
Analyst Recom | 3.00 | Target Price | 0.50 |
Avg Volume | 1.08M | 52W Range | 0.14 - 1.02 |
|
|
|
Acutus Medical, Inc. engages in the development of medical devices and electrophy equipment. It creates electrophysiological mapping systems for the treatment of cardiac arrhythmias, such as atrial fibrillation, and ventricular tachycardia. The company was founded by Randell L. Werneth and Christoph Scharf in 2011 and is headquartered in Carlsbad, CA. |
|
|
|
Market Cap | 1.81B | EPS (ttm) | 0.84 |
P/E | 27.44 | EPS this Y | -0.80% |
Forward P/E | 6.83 | EPS next Y | 10.12% |
PEG | 3.12 | EPS past 5Y | 3.10% |
P/S | 1.17 | EPS next 5Y | 8.80% |
P/B | 1.14 | EPS Q/Q | -59.99% |
Dividend | - | Sales Q/Q | -0.25% |
Insider Own | 15.36% | Inst Own | 84.97% |
Insider Trans | -0.07% | Inst Trans | 1.28% |
Short Float | 3.95% | Earnings | May 06/b |
Analyst Recom | 2.86 | Target Price | 34.50 |
Avg Volume | 899.79K | 52W Range | 27.18 - 51.12 |
|
|
Today | Downgrade |
Wells Fargo |
Overweight → Equal Weight |
$45 → $25 |
Today | Downgrade |
Oppenheimer |
Outperform → Perform |
|
|
Today 03:02AM
|
Integra Lifesciences Holdings Corp (IART) Q1 2024 Earnings Call Transcript Highlights: ...
(GuruFocus.com) |
01:45AM
|
Q1 2024 Integra Lifesciences Holdings Corp Earnings Call
(Thomson Reuters StreetEvents) |
May-06-24 01:23PM
|
Why Is Medical Device Maker Integra LifeSciences Stock Falling On Monday?
(Benzinga) -19.90% |
12:35PM
|
BioCryst Pharmaceuticals, Freshpet rise; Luminar, Integra fall, Tuesday, 5/6/2024
(Associated Press) |
12:35PM
|
BioCryst Pharmaceuticals, Freshpet rise; Luminar, Integra fall, Monday, 5/6/2024
(Associated Press Finance) |
10:53AM
|
IART Stock Earnings: Integra Lifesciences Meets EPS, Beats Revenue for Q1 2024
(InvestorPlace) |
09:30AM
|
Integra (IART) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
(Zacks) |
06:29AM
|
Integra LifeSciences Q1 Adjusted Earnings, Revenue Fall; Updates 2024 Outlook
(MT Newswires) |
06:10AM
|
Integra: Q1 Earnings Snapshot
(Associated Press Finance) |
06:00AM
|
Integra LifeSciences Reports First Quarter 2024 Financial Results
(GlobeNewswire) |
|
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
De Witte Jan | President & CEO | Mar 11 '24 | Option Exercise | 0.00 | 205 | 0 | 18,555 | Mar 13 04:30 PM | Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL | Mar 10 '24 | Option Exercise | 0.00 | 1,179 | 0 | 1,179 | Mar 12 05:10 PM | De Witte Jan | President & CEO | Mar 10 '24 | Option Exercise | 0.00 | 346 | 0 | 18,696 | Mar 12 05:12 PM | DAVIS ROBERT T. JR. | EVP & President, TT | Mar 06 '24 | Option Exercise | 32.59 | 8,736 | 284,663 | 58,241 | Mar 08 04:22 PM | DAVIS ROBERT T. JR. | EVP & President, TT | Mar 06 '24 | Sale | 36.59 | 8,348 | 305,492 | 49,893 | Mar 08 04:22 PM |
|
|
| |
|
Market Cap | 87.04M | EPS (ttm) | - |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | 53.46% | Inst Own | - |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.30% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 7.00 |
Avg Volume | 6.12M | 52W Range | 2.92 - 29.50 |
|
|
|
Mobile-health Network Solutions operates as an investment holding company. The company through its subsidiaries provides telehealth solutions through MaNaDr platform. The platform seeks to offer users the ability to teleconsult with doctors and prescribed and delivered with the medication at their doorsteps. The company's segments include: Telemedicine and Other Services, and Sale of Medicine and Medical Devices. The Telemedicine and Other Services segment includes providing teleconsultation services to patients from both private and public sector. The Sale of Medicine and Medical Devices segment focuses on selling prescription drugs, non-prescription drugs, and healthcare products to clinics and end customers offline and online. The company was founded by Tung Yeng Siaw and Pui Pui Teoh on July 28, 2016 and is headquartered in Singapore. |
|
|
|
Market Cap | 3.16M | EPS (ttm) | -2.23 |
P/E | - | EPS this Y | 54.40% |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 10.53 | EPS next 5Y | - |
P/B | - | EPS Q/Q | 6.90% |
Dividend | - | Sales Q/Q | -99.30% |
Insider Own | 10.29% | Inst Own | 0.04% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 2.65% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 1.90M | 52W Range | 0.15 - 5.88 |
|
|
|
Vocodia Holdings Corp develops a conversational artificial intelligence (AI) sales and customer service software. The company offers DISA, a humanized conversational AI technology, that can complete each stage of the conversational aspect of the sales process, business-to-business, and business-to-consumer. It also offers IT services. The company was founded in 2020 and is based in Boca Raton, Florida. |
|
| |
|
Market Cap | 15.90M | EPS (ttm) | - |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | 68.27% | Inst Own | - |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | - | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 3.37M | 52W Range | 1.32 - 14.49 |
|
|
|
mF International Ltd. is a holding company, which engages in the development and provision of financial trading solutions through its subsidiary. It offers real-time mission critical forex, bullion and commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via internet or platform as software as a service. The company was founded by Tai Wai Lam and Chi Weng Tam on June 15, 2022 and is headquartered in Hong Kong. |
|
|
|
Market Cap | 17.78M | EPS (ttm) | 0.90 |
P/E | 1.65 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 0.45 | EPS next 5Y | - |
P/B | 0.13 | EPS Q/Q | -578.53% |
Dividend | - | Sales Q/Q | -6.98% |
Insider Own | 0.35% | Inst Own | - |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.65% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 217.97K | 52W Range | 1.57 - 18.78 |
|
|
|
Wetouch Technology, Inc. engages in provision of consulting services. The company was founded on August 28, 1992 and is headquartered in Meishan, China. |
|
| |
|
Market Cap | 17.34M | EPS (ttm) | -0.48 |
P/E | - | EPS this Y | 39.29% |
Forward P/E | - | EPS next Y | 33.82% |
PEG | - | EPS past 5Y | -175.54% |
P/S | 0.68 | EPS next 5Y | - |
P/B | - | EPS Q/Q | 38.77% |
Dividend | - | Sales Q/Q | -25.79% |
Insider Own | 57.09% | Inst Own | 10.58% |
Insider Trans | 0.00% | Inst Trans | 104.27% |
Short Float | 6.18% | Earnings | May 03/a |
Analyst Recom | 1.00 | Target Price | 2.50 |
Avg Volume | 222.71K | 52W Range | 0.25 - 4.66 |
|
|
|
Loop Media, Inc. engages in curating and distributing short-form videos to out-of-home dining, hospitality, retail, convenience stores, and other locations and venues. The firm offers hand-curated music video content licensed from major and independent record labels, including Universal Music Group, Sony Music Entertainment, and Warner Music Group. The company was founded by Liam McCallum, Jon Niermann, and Shawn Driscoll on May 18, 2016 and is headquartered in Burbank, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Cassidy Bruce A. Sr. | Director | Dec 14 '23 | Option Exercise | 0.80 | 786,482 | 629,186 | 13,378,225 | Dec 18 06:27 PM | Penz Denise M. | Director | Dec 14 '23 | Option Exercise | 0.80 | 443,332 | 354,666 | 699,668 | Dec 18 06:31 PM |
|
|
|
|
Market Cap | 357.56M | EPS (ttm) | - |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | - | Inst Own | 0.00% |
Insider Trans | - | Inst Trans | - |
Short Float | 0.04% | Earnings | Feb 14/b |
Analyst Recom | - | Target Price | - |
Avg Volume | 98.04K | 52W Range | 2.91 - 21.97 |
|
|
|
Nature Wood Group Ltd. is a holding company, which engages in forest management, harvesting and down-stream wood processing and distribution of logs, decking, flooring, and sawn timber products. It operates through the Direct Purchase and ODM, and Manufacturing Segments. The Direct Purchase and ODM segment represent sourcing of live wood and owning designed design on wood products for sales to end customers. The Manufacturing segment is involved in manufacturing decking, flooring, or sawn timbers. The company was founded on September 22, 2011 and is headquartered in Macau, China. |
|
|
|
Market Cap | 1.54M | EPS (ttm) | -9.76 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 37.15% |
P/S | - | EPS next 5Y | 4.00% |
P/B | 0.17 | EPS Q/Q | 85.72% |
Dividend | - | Sales Q/Q | - |
Insider Own | 18.62% | Inst Own | 12.68% |
Insider Trans | 0.00% | Inst Trans | -35.59% |
Short Float | 0.80% | Earnings | - |
Analyst Recom | 2.33 | Target Price | 200.00 |
Avg Volume | 249.38K | 52W Range | 0.39 - 4.80 |
|
|
|
NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm's therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on August 4, 2009 and is headquartered in Pittsburgh, PA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Symetryx Corp | 10% Owner | Sep 14 '23 | Sale | 1.44 | 129,108 | 185,916 | 153,337 | Sep 18 04:32 PM | Symetryx Corp | 10% Owner | Sep 11 '23 | Sale | 1.44 | 3,376 | 4,861 | 472,926 | Sep 11 05:08 PM | Symetryx Corp | 10% Owner | Sep 08 '23 | Sale | 1.53 | 128,847 | 197,136 | 476,302 | Sep 11 05:08 PM | Symetryx Corp | 10% Owner | Sep 07 '23 | Sale | 1.80 | 74,852 | 134,734 | 605,149 | Sep 11 05:08 PM | Symetryx Corp | 10% Owner | Sep 01 '23 | Buy | 0.98 | 61,076 | 59,732 | 680,081 | Sep 07 05:19 PM |
|
|
|